| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Detected and Quantified |
|---|
| Creation Date | 2005-11-16 15:48:42 UTC |
|---|
| Update Date | 2023-05-30 20:55:51 UTC |
|---|
| HMDB ID | HMDB0000630 |
|---|
| Secondary Accession Numbers | |
|---|
| Metabolite Identification |
|---|
| Common Name | Cytosine |
|---|
| Description | Cytosine, also known as C, belongs to the class of organic compounds known as pyrimidones. Pyrimidones are compounds that contain a pyrimidine ring, which bears a ketone. Pyrimidine is a 6-membered ring consisting of four carbon atoms and two nitrogen centers at the 1- and 3- ring positions. Cytosine is also classified as a pyrimidine derivative, with a heterocyclic aromatic ring and two substituents attached (an amine group at position 4 and a keto group at position 2). Cytosine is one of the four main bases found in DNA and RNA, along with adenine, guanine, and thymine (uracil in RNA). The nucleoside of cytosine is cytidine. In Watson-Crick base pairing, cytosine forms three hydrogen bonds with guanine. Cytosine was discovered and named by Albrecht Kossel and Albert Neumann in 1894 when it was hydrolyzed from calf thymus tissues. Cytosine exists in all living species, ranging from bacteria to plants to humans. Within cells, cytosine can undergo several enzymatic reactions. It can be methylated into 5-methylcytosine by an enzyme called DNA methyltransferase (DNMT) or be methylated and hydroxylated to make 5-hydroxymethylcytosine. The DNA methyltransferase (DNMT) family of enzymes transfer a methyl group from S-adenosyl-l-methionine (SAM) to the 5’ carbon of cytosine in a molecule of DNA. High levels of cytosine can be found in the urine of individuals with severe combined immunodeficiency syndrome (SCID). Cytosine concentrations as high as (23-160 mmol/mol creatinine) were detected in SCID patients compared to normal levels of <2 mmol/mol creatinine (PMID: 262183 ). |
|---|
| Structure | InChI=1S/C4H5N3O/c5-3-1-2-6-4(8)7-3/h1-2H,(H3,5,6,7,8) |
|---|
| Synonyms | | Value | Source |
|---|
| 4-Amino-2(1H)-pyrimidinone | ChEBI | | 4-Amino-2-hydroxypyrimidine | ChEBI | | C | ChEBI | | Cyt | ChEBI | | Cytosin | ChEBI | | Zytosin | ChEBI | | 4-Amino-2-oxo-1,2-dihydropyrimidine | HMDB | | 4-Aminouracil | HMDB | | Cytosinimine | HMDB |
|
|---|
| Chemical Formula | C4H5N3O |
|---|
| Average Molecular Weight | 111.102 |
|---|
| Monoisotopic Molecular Weight | 111.043261797 |
|---|
| IUPAC Name | 6-amino-1,2-dihydropyrimidin-2-one |
|---|
| Traditional Name | 2(1H)-pyrimidinone, 6-amino- |
|---|
| CAS Registry Number | 71-30-7 |
|---|
| SMILES | NC1=CC=NC(=O)N1 |
|---|
| InChI Identifier | InChI=1S/C4H5N3O/c5-3-1-2-6-4(8)7-3/h1-2H,(H3,5,6,7,8) |
|---|
| InChI Key | OPTASPLRGRRNAP-UHFFFAOYSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as pyrimidones. Pyrimidones are compounds that contain a pyrimidine ring, which bears a ketone. Pyrimidine is a 6-membered ring consisting of four carbon atoms and two nitrogen centers at the 1- and 3- ring positions. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Organoheterocyclic compounds |
|---|
| Class | Diazines |
|---|
| Sub Class | Pyrimidines and pyrimidine derivatives |
|---|
| Direct Parent | Pyrimidones |
|---|
| Alternative Parents | |
|---|
| Substituents | - Pyrimidone
- Aminopyrimidine
- Hydropyrimidine
- Heteroaromatic compound
- Azacycle
- Organic nitrogen compound
- Organic oxygen compound
- Organopnictogen compound
- Organic oxide
- Hydrocarbon derivative
- Primary amine
- Organooxygen compound
- Organonitrogen compound
- Amine
- Aromatic heteromonocyclic compound
|
|---|
| Molecular Framework | Aromatic heteromonocyclic compounds |
|---|
| External Descriptors | |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | Not Available |
|---|
| Role | Not Available |
|---|
| Physical Properties |
|---|
| State | Solid |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | > 300 °C | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | 8 mg/mL | Not Available | | LogP | -1.73 | HANSCH,C ET AL. (1995) |
|
|---|
| Experimental Chromatographic Properties | Experimental Collision Cross Sections |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022. | 1.4 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 8.3146 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 4.43 minutes | 32390414 | | AjsUoB = Accucore 150 Amide HILIC with 10mM Ammonium Formate, 0.1% Formic Acid | 174.5 seconds | 40023050 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 409.3 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 326.7 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 66.4 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 230.8 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 83.9 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 274.8 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 237.8 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 805.0 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 549.0 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 35.1 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 593.6 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 205.8 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 280.8 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 681.7 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 416.7 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 232.2 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| Cytosine,1TMS,isomer #1 | C[Si](C)(C)NC1=CC=NC(=O)[NH]1 | 1587.0 | Semi standard non polar | 33892256 | | Cytosine,1TMS,isomer #1 | C[Si](C)(C)NC1=CC=NC(=O)[NH]1 | 1613.2 | Standard non polar | 33892256 | | Cytosine,1TMS,isomer #1 | C[Si](C)(C)NC1=CC=NC(=O)[NH]1 | 2082.3 | Standard polar | 33892256 | | Cytosine,1TMS,isomer #2 | C[Si](C)(C)N1C(N)=CC=NC1=O | 1486.2 | Semi standard non polar | 33892256 | | Cytosine,1TMS,isomer #2 | C[Si](C)(C)N1C(N)=CC=NC1=O | 1528.3 | Standard non polar | 33892256 | | Cytosine,1TMS,isomer #2 | C[Si](C)(C)N1C(N)=CC=NC1=O | 2182.9 | Standard polar | 33892256 | | Cytosine,2TMS,isomer #1 | C[Si](C)(C)N(C1=CC=NC(=O)[NH]1)[Si](C)(C)C | 1465.9 | Semi standard non polar | 33892256 | | Cytosine,2TMS,isomer #1 | C[Si](C)(C)N(C1=CC=NC(=O)[NH]1)[Si](C)(C)C | 1640.2 | Standard non polar | 33892256 | | Cytosine,2TMS,isomer #1 | C[Si](C)(C)N(C1=CC=NC(=O)[NH]1)[Si](C)(C)C | 1937.1 | Standard polar | 33892256 | | Cytosine,2TMS,isomer #2 | C[Si](C)(C)NC1=CC=NC(=O)N1[Si](C)(C)C | 1630.6 | Semi standard non polar | 33892256 | | Cytosine,2TMS,isomer #2 | C[Si](C)(C)NC1=CC=NC(=O)N1[Si](C)(C)C | 1686.1 | Standard non polar | 33892256 | | Cytosine,2TMS,isomer #2 | C[Si](C)(C)NC1=CC=NC(=O)N1[Si](C)(C)C | 1890.2 | Standard polar | 33892256 | | Cytosine,3TMS,isomer #1 | C[Si](C)(C)N(C1=CC=NC(=O)N1[Si](C)(C)C)[Si](C)(C)C | 1665.1 | Semi standard non polar | 33892256 | | Cytosine,3TMS,isomer #1 | C[Si](C)(C)N(C1=CC=NC(=O)N1[Si](C)(C)C)[Si](C)(C)C | 1745.1 | Standard non polar | 33892256 | | Cytosine,3TMS,isomer #1 | C[Si](C)(C)N(C1=CC=NC(=O)N1[Si](C)(C)C)[Si](C)(C)C | 1741.5 | Standard polar | 33892256 | | Cytosine,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)NC1=CC=NC(=O)[NH]1 | 1816.5 | Semi standard non polar | 33892256 | | Cytosine,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)NC1=CC=NC(=O)[NH]1 | 1835.0 | Standard non polar | 33892256 | | Cytosine,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)NC1=CC=NC(=O)[NH]1 | 2245.7 | Standard polar | 33892256 | | Cytosine,1TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)N1C(N)=CC=NC1=O | 1704.5 | Semi standard non polar | 33892256 | | Cytosine,1TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)N1C(N)=CC=NC1=O | 1746.2 | Standard non polar | 33892256 | | Cytosine,1TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)N1C(N)=CC=NC1=O | 2257.7 | Standard polar | 33892256 | | Cytosine,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N(C1=CC=NC(=O)[NH]1)[Si](C)(C)C(C)(C)C | 1908.4 | Semi standard non polar | 33892256 | | Cytosine,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N(C1=CC=NC(=O)[NH]1)[Si](C)(C)C(C)(C)C | 2051.7 | Standard non polar | 33892256 | | Cytosine,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N(C1=CC=NC(=O)[NH]1)[Si](C)(C)C(C)(C)C | 2098.0 | Standard polar | 33892256 | | Cytosine,2TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)NC1=CC=NC(=O)N1[Si](C)(C)C(C)(C)C | 2030.7 | Semi standard non polar | 33892256 | | Cytosine,2TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)NC1=CC=NC(=O)N1[Si](C)(C)C(C)(C)C | 2101.7 | Standard non polar | 33892256 | | Cytosine,2TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)NC1=CC=NC(=O)N1[Si](C)(C)C(C)(C)C | 2075.6 | Standard polar | 33892256 | | Cytosine,3TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N(C1=CC=NC(=O)N1[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2252.3 | Semi standard non polar | 33892256 | | Cytosine,3TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N(C1=CC=NC(=O)N1[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2351.3 | Standard non polar | 33892256 | | Cytosine,3TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N(C1=CC=NC(=O)N1[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2081.0 | Standard polar | 33892256 |
|
|---|
| GC-MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Experimental GC-MS | GC-MS Spectrum - Cytosine GC-EI-TOF (Pegasus III TOF-MS system, Leco; GC 6890, Agilent Technologies) (Non-derivatized) | splash10-0udm-3970000000-a0532c16ce6140949915 | 2014-06-16 | HMDB team, MONA, MassBank | View Spectrum | | Experimental GC-MS | GC-MS Spectrum - Cytosine GC-MS (2 TMS) | splash10-0udl-4790000000-f8d777863969fe9feeee | 2014-06-16 | HMDB team, MONA, MassBank | View Spectrum | | Experimental GC-MS | GC-MS Spectrum - Cytosine GC-MS (3 TMS) | splash10-0h6s-2914000000-5c0c43de53d8e6d5ff65 | 2014-06-16 | HMDB team, MONA, MassBank | View Spectrum | | Experimental GC-MS | GC-MS Spectrum - Cytosine GC-EI-TOF (Non-derivatized) | splash10-0udm-3970000000-a0532c16ce6140949915 | 2017-09-12 | HMDB team, MONA, MassBank | View Spectrum | | Experimental GC-MS | GC-MS Spectrum - Cytosine GC-MS (Non-derivatized) | splash10-0udl-4790000000-f8d777863969fe9feeee | 2017-09-12 | HMDB team, MONA, MassBank | View Spectrum | | Experimental GC-MS | GC-MS Spectrum - Cytosine GC-MS (Non-derivatized) | splash10-0h6s-2914000000-5c0c43de53d8e6d5ff65 | 2017-09-12 | HMDB team, MONA, MassBank | View Spectrum | | Experimental GC-MS | GC-MS Spectrum - Cytosine GC-EI-TOF (Non-derivatized) | splash10-0f6w-4960000000-b053578e0f2ae00d0808 | 2017-09-12 | HMDB team, MONA, MassBank | View Spectrum | | Experimental GC-MS | GC-MS Spectrum - Cytosine GC-EI-TOF (Non-derivatized) | splash10-0gxt-0914000000-bdca724db358d4bc5ccb | 2017-09-12 | HMDB team, MONA, MassBank | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Cytosine GC-MS (Non-derivatized) - 70eV, Positive | splash10-03di-9400000000-109300546706ee372e62 | 2016-09-22 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Cytosine GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Experimental LC-MS/MS | LC-MS/MS Spectrum - Cytosine Quattro_QQQ 10V, Positive-QTOF (Annotated) | splash10-03di-1900000000-ce9c385be713873945a4 | 2012-07-24 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Cytosine Quattro_QQQ 25V, Positive-QTOF (Annotated) | splash10-00kf-9100000000-5d27ff55f5080da7aaf0 | 2012-07-24 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Cytosine Quattro_QQQ 40V, Positive-QTOF (Annotated) | splash10-0006-9100000000-585d7d52c8ceb70d1b25 | 2012-07-24 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Cytosine LC-ESI-ITFT (LTQ Orbitrap XL, Thermo Scientfic) , Positive-QTOF | splash10-03k9-0970000000-1491957a90e606f28d03 | 2012-08-31 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Cytosine LC-ESI-ITFT (LTQ Orbitrap XL, Thermo Scientfic) , Positive-QTOF | splash10-0006-9000000000-f79bcd2133156449152c | 2012-08-31 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Cytosine LC-ESI-ITFT (LTQ Orbitrap XL, Thermo Scientfic) , Positive-QTOF | splash10-03di-0900000000-155769b79f7f2d14ee92 | 2012-08-31 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Cytosine LC-ESI-ITFT (LTQ Orbitrap XL, Thermo Scientfic) , Positive-QTOF | splash10-03di-0900000000-4b1d0c842bcd05ceed1b | 2012-08-31 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Cytosine LC-ESI-ITFT (LTQ Orbitrap XL, Thermo Scientfic) , Positive-QTOF | splash10-03di-0910000000-7cd7c6a6f6e7c02ed6f1 | 2012-08-31 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Cytosine LC-ESI-ITFT (LTQ Orbitrap XL, Thermo Scientfic) , Positive-QTOF | splash10-0006-9000000000-71a5fe9af8fc82824d54 | 2012-08-31 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Cytosine LC-ESI-ITFT (LTQ Orbitrap XL, Thermo Scientfic) , Positive-QTOF | splash10-014i-0900000000-a210a634771936e0ffd6 | 2012-08-31 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Cytosine LC-ESI-ITFT (LTQ Orbitrap XL, Thermo Scientfic) , Positive-QTOF | splash10-03di-0900000000-084e35ced5f5834ca93e | 2012-08-31 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Cytosine LC-ESI-QQ (API3000, Applied Biosystems) 10V, Negative-QTOF | splash10-03di-0900000000-d23ab5cfeba2d0a6ccff | 2012-08-31 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Cytosine LC-ESI-QQ (API3000, Applied Biosystems) 20V, Negative-QTOF | splash10-02tc-9500000000-3b81b2a441135c25b1e3 | 2012-08-31 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Cytosine LC-ESI-QQ (API3000, Applied Biosystems) 30V, Negative-QTOF | splash10-00kf-9000000000-e57731b8ed024624cf7a | 2012-08-31 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Cytosine LC-ESI-QQ (API3000, Applied Biosystems) 40V, Negative-QTOF | splash10-0006-9000000000-a1679050e95cc271b8b7 | 2012-08-31 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Cytosine LC-ESI-QQ (API3000, Applied Biosystems) 50V, Negative-QTOF | splash10-0006-9000000000-57b23eb60e1f7ce1ca97 | 2012-08-31 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Cytosine LC-ESI-QQ , negative-QTOF | splash10-03di-0900000000-d23ab5cfeba2d0a6ccff | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Cytosine LC-ESI-QQ , negative-QTOF | splash10-02tc-9500000000-b9d5621a816bed354c10 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Cytosine LC-ESI-QQ , negative-QTOF | splash10-00kf-9000000000-e57731b8ed024624cf7a | 2017-09-14 | HMDB team, MONA | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Cytosine 10V, Positive-QTOF | splash10-03di-1900000000-4047bc076c5529ab5953 | 2015-05-27 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Cytosine 20V, Positive-QTOF | splash10-03dj-9600000000-4b29d871234eed6b5e40 | 2015-05-27 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Cytosine 40V, Positive-QTOF | splash10-0uxv-9000000000-e7c1aa90d5d06c5c13b4 | 2015-05-27 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Cytosine 10V, Negative-QTOF | splash10-03di-2900000000-b19c12744f9718502007 | 2015-05-27 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Cytosine 20V, Negative-QTOF | splash10-014i-9100000000-1cf86d26f0f1d0794e0d | 2015-05-27 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Cytosine 40V, Negative-QTOF | splash10-0006-9000000000-51460ed94e186a6f38e0 | 2015-05-27 | Wishart Lab | View Spectrum |
NMR Spectra| Spectrum Type | Description | Deposition Date | Source | View |
|---|
| Experimental 1D NMR | 1H NMR Spectrum (1D, 600 MHz, H2O, experimental) | 2012-12-04 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Experimental 2D NMR | [1H, 13C]-HSQC NMR Spectrum (2D, 600 MHz, H2O, experimental) | 2012-12-05 | Wishart Lab | View Spectrum |
IR Spectra| Spectrum Type | Description | Deposition Date | Source | View |
|---|
| Predicted IR Spectrum | IR Ion Spectrum (Quadrupole Ion Trap, ESI-, Adduct: [M-H]-) | 2022-02-11 | FELIX lab | View Spectrum | | Predicted IR Spectrum | IR Ion Spectrum (Quadrupole Ion Trap, ESI+, Adduct: [M+Na]+) | 2022-02-11 | FELIX lab | View Spectrum | | Predicted IR Spectrum | IR Ion Spectrum (Quadrupole Ion Trap, ESI+, Adduct: [M+H]+) | 2022-02-11 | FELIX lab | View Spectrum | | Predicted IR Spectrum | IR Ion Spectrum (Predicted IRIS Spectrum, Adduct: [M-H]-) | 2023-02-03 | FELIX lab | View Spectrum | | Predicted IR Spectrum | IR Ion Spectrum (Predicted IRIS Spectrum, Adduct: [M+H]+) | 2023-02-03 | FELIX lab | View Spectrum | | Predicted IR Spectrum | IR Ion Spectrum (Predicted IRIS Spectrum, Adduct: [M+Na]+) | 2023-02-03 | FELIX lab | View Spectrum |
|
|---|
| General References | - Mills GC, Schmalstieg FC, Newkirk KE, Goldblum RM: Cytosine and orotic acid in urine of immunodeficient children. Clin Chem. 1979 Mar;25(3):419-24. [PubMed:262183 ]
- Rodriguez Ortner E, Hayes RB, Weissfeld J, Gelmann EP: Effect of homeodomain protein NKX3.1 R52C polymorphism on prostate gland size. Urology. 2006 Feb;67(2):311-5. Epub 2006 Jan 25. [PubMed:16442598 ]
- Harvey BG, Maroni J, O'Donoghue KA, Chu KW, Muscat JC, Pippo AL, Wright CE, Hollmann C, Wisnivesky JP, Kessler PD, Rasmussen HS, Rosengart TK, Crystal RG: Safety of local delivery of low- and intermediate-dose adenovirus gene transfer vectors to individuals with a spectrum of morbid conditions. Hum Gene Ther. 2002 Jan 1;13(1):15-63. [PubMed:11779412 ]
- Cheng JC, Yoo CB, Weisenberger DJ, Chuang J, Wozniak C, Liang G, Marquez VE, Greer S, Orntoft TF, Thykjaer T, Jones PA: Preferential response of cancer cells to zebularine. Cancer Cell. 2004 Aug;6(2):151-8. [PubMed:15324698 ]
- Carotti D, Funiciello S, Lavia P, Caiafa P, Strom R: Different effects of histone H1 on de novo DNA methylation in vitro depend on both the DNA base composition and the DNA methyltransferase. Biochemistry. 1996 Sep 10;35(36):11660-7. [PubMed:8794746 ]
- Tawa R, Ueno S, Yamamoto K, Yamamoto Y, Sagisaka K, Katakura R, Kayama T, Yoshimoto T, Sakurai H, Ono T: Methylated cytosine level in human liver DNA does not decline in aging process. Mech Ageing Dev. 1992 Mar 1;62(3):255-61. [PubMed:1583911 ]
- Tsuchiya K, Tajima H, Yamada M, Takahashi H, Kuwae T, Sunaga K, Katsube N, Ishitani R: Disclosure of a pro-apoptotic glyceraldehyde-3-phosphate dehydrogenase promoter: anti-dementia drugs depress its activation in apoptosis. Life Sci. 2004 May 14;74(26):3245-58. [PubMed:15094325 ]
- Putta MR, Zhu F, Li Y, Bhagat L, Cong Y, Kandimalla ER, Agrawal S: Novel oligodeoxynucleotide agonists of TLR9 containing N3-Me-dC or N1-Me-dG modifications. Nucleic Acids Res. 2006 Jun 23;34(11):3231-8. Print 2006. [PubMed:16798912 ]
- Bawdon RE, Sobhi S, Dax J: The transfer of anti-human immunodeficiency virus nucleoside compounds by the term human placenta. Am J Obstet Gynecol. 1992 Dec;167(6):1570-4. [PubMed:1335207 ]
- Sawamura D, Abe R, Goto M, Akiyama M, Hemmi H, Akira S, Shimizu H: Direct injection of plasmid DNA into the skin induces dermatitis by activation of monocytes through toll-like receptor 9. J Gene Med. 2005 May;7(5):664-71. [PubMed:15655803 ]
- Thajeb P, Ma YS, Tzen CY, Chuang CK, Wu TY, Chen SC, Wei YH: Oculopharyngeal somatic myopathy in a patient with a novel large-scale 3,399 bp deletion and a homoplasmic T5814C transition of the mitochondrial DNA. Clin Neurol Neurosurg. 2006 Jun;108(4):407-10. [PubMed:16644408 ]
- Sigalotti L, Coral S, Nardi G, Spessotto A, Cortini E, Cattarossi I, Colizzi F, Altomonte M, Maio M: Promoter methylation controls the expression of MAGE2, 3 and 4 genes in human cutaneous melanoma. J Immunother. 2002 Jan-Feb;25(1):16-26. [PubMed:11924907 ]
- Costa E, Grayson DR, Mitchell CP, Tremolizzo L, Veldic M, Guidotti A: GABAergic cortical neuron chromatin as a putative target to treat schizophrenia vulnerability. Crit Rev Neurobiol. 2003;15(2):121-42. [PubMed:14977367 ]
- Machwe A, Orren DK, Bohr VA: Accelerated methylation of ribosomal RNA genes during the cellular senescence of Werner syndrome fibroblasts. FASEB J. 2000 Sep;14(12):1715-24. [PubMed:10973920 ]
- Elshenawy S, Pinney SE, Stuart T, Doulias PT, Zura G, Parry S, Elovitz MA, Bennett MJ, Bansal A, Strauss JF 3rd, Ischiropoulos H, Simmons RA: The Metabolomic Signature of the Placenta in Spontaneous Preterm Birth. Int J Mol Sci. 2020 Feb 4;21(3). pii: ijms21031043. doi: 10.3390/ijms21031043. [PubMed:32033212 ]
|
|---|